FB News 58.02 05/19/2014 04:53:28 Facebook Inc (FB)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Facebook Inc (FB) 58.02 $FB

Facebook Stock Turns 2: How Zuckerberg Shocked Everyone
Daniel Sparks, The Motley Fool - Motley Fool - Sun May 18, 3:30PM CDT
Two years ago today, Facebook began trading on the stock market under ticker symbol FB. With already nearly 1 billion monthly active users at the time, roughly one out of seven people on earth were familiar with the social network. The IPO was...

Why Aren’t Movie Studios Backing This Social Network?
Tim Beyers, The Motley Fool - Motley Fool - Sun May 18, 7:15AM CDT
A new social network for movie aficionados could help movie studios find their audiences faster, Fool contributor Tim Beyers says in the following video. Known as MovieLaLa, the service proposes to connect would-be audience members with movies they...

Tech Banquet Gone Before Investors Get a Bite
at The Street - Sat May 17, 9:00AM CDT
Technology companies no longer need Wall Street. They can be created, fully funded, and sold off to big companies while small investors look on enviously.

'Fast Money' Recap: Fleeing to Safety
at The Street - Sat May 17, 4:00AM CDT
The trading panel discussed how high the S&P 500 can go next week.

Unilever Video Ads Now on Facebook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 16, 5:20PM CDT
Recently, video ads were placed on the social networking giant Facebook (FB) by Unilever (UN), promoting its Dove soap product.

Most active Nasdaq-traded stocks
AP - Fri May 16, 5:06PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:

Final Hour: Stocks Tentatively Higher With Few Other Options
at The Street - Fri May 16, 2:21PM CDT
Equities were tentatively higher in late Friday trade, with markets off their panic levels from a day earlier.

Could a Pinterest IPO Be Bigger Than Twitter or Facebook?
Leo Sun, The Motley Fool - Motley Fool - Fri May 16, 9:19AM CDT
Could Pinterest, the third most popular social network in the U.S. after Facebook and Twitter , file for an IPO soon? Recent growth numbers, funding, and monetization strategies certainly suggest that it could be...

Active Stocks Pre-Market Notes -- Research on Bank of America, Facebook, General Electric, and Petroleo Brasileiro
PR Newswire - Fri May 16, 8:20AM CDT
The markets on Thursday, May 15, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,446.81, down 1.01% and the NASDAQ Composite closed at 4,069.29, down 0.76%. The S&P 500 edged 0.94% lower, to finish the day at 1,870.85. The losses were broad based as nine out of ten sectors ended the session in negative. The losses in Financials, Energy and Materials sectors negatively impacted the market, while some positive momentum was observed in the Telecommunication Services sector. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Bank of America Corporation (NYSE: BAC), Facebook Inc. (NASDAQ: FB), General Electric Company (NYSE: GE) and Petroleo Brasileiro S.A. (NYSE: PBR). Free technical research on BAC, FB, GE and PBR can be downloaded upon signing up at:

Google Glass Gets a New Boss
at The Street - Fri May 16, 8:19AM CDT
Google has hired marketing guru Ivy Ross to help change its head-mounted computers from geek to chic.

Michael Kors Is Poised for a Great Quarter
Andrew Sebastian, The Motley Fool - Motley Fool - Thu May 15, 4:00PM CDT
Michael Kors will announce its earnings for 2014's fourth quarter on May 28, 2014. The luxury designer and retailer reported a great prior quarter with net income of $229.6 million, earnings per share of $1.11, and revenue of $1.0 billion. The...

Stocks Post Heavy Losses; J.C. Penney Surges in Afterhours
at The Street - Thu May 15, 3:29PM CDT
U.S. markets post heavy losses Thursday amid mixed economic data while retail stocks generally fall on lackluster earnings. J.C. Penney Surges in afterhours trading after a better-than-expected earnings report.

Yahoo Buys Blink Messaging App - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 15, 3:04PM CDT
Yahoo! (YHOO) recently acquired Blink, a mobile messaging application that allows users to share messages, which are automatically deleted at a time preset by the user.

Jill Abramson Firing Immaterial to Analysts
at The Street - Thu May 15, 1:54PM CDT
The abrupt firing of Jill Abramson, the first female Executive Editor of the New York Times may have created a media sensation, with reports indicating Abramson's firing resulted from a pay dispute, in-fighting among newsroom executives, a drop-off...

Google Brings Glass to US for $1,500 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 15, 1:00PM CDT
Soon after the limited one-day sale of Google Glass in April this year, Google, Inc. (GOOGL) announced that its Glass wearable device will be available across the U.S. for $1,500.

If You Like Twitter at $35, You’ll Love These 2 Stocks
Brian Nichols, The Motley Fool - Motley Fool - Thu May 15, 12:05PM CDT
Twitter has bounced 15% off its $29.51 lows and appears to be headed back over $35 per share. The social media company has been criticized for its slowing user growth, as the need for better monetization tools have many wondering if it could ever...

Why Facebook (FB) Stock Is Down Today
at The Street - Thu May 15, 11:14AM CDT
Facebook (FB) fell Thursday after the FCC voted 3-2 in favor of formally proposing new "net neutrality" rules.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading